DCISionRT® – the only DCIS test to predict radiation therapy benefit

Request a test

Understand the best treatment options for your DCIS

DCISionRT is a risk assessment test which looks at the likelihood of your ductal carcinoma in situ (DCIS) recurring after surgery, the risk of the disease spreading, and the impact of radiation therapy in reducing that risk.

DCISionRT assists you and your doctor to select treatment based on the biology of your tumour, in addition to clinical pathology.

DCIS itself is not considered life threatening, however, a recent study suggested that women with DCIS have a 3-fold increased risk of death from breast cancer compared with women without DCIS because of the variations in treatment practice, due to geographical access and differing clinical protocols.1, 2

DCISionRT is a validated precision medicine test that provides information about a patient’s biological risk profile, assisting women to make informed and personalised treatment decisions.

There are no additional procedures required to complete the test – DCISionRT is done using the existing tissue from the biopsy or breast surgery. 

For more information ask your doctor or contact us directly.

1300 086 870
1300 086 870

Click here to find out more about the treatment journey for breast cancer and DCISionRT at GenesisCare.

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

Our staff will provide answers to your questions withing 24 hours. Otherwise, if you have a medical emergency please call 000.

*Indicates a required field

Request a test

We understand that this is a very stressful time. We’re here to help. Contact us directly at 1300 086 870 for questions about the DCISionRT test.

Contact us

References

  1. https://www.aihw.gov.au/getmedia/e414a344-ab3d-4a35-a79b-a29723f22939/aihw-can-135.pdf
  2. van Seijen M, et al. Br J Cancer 2019; 13;121(4):285–292
  3. https://preludedx.com/dcisionrt/
  4. Weinmann S, et al. Clin Cancer Res 2020; (26)(15):4054-4063
  5. Bremer TM, et al. Clin Cancer Res 2018; 1;24(23):5895-5901.
  6. Warnberg F, et al. Cancer Res 2018; 78 (4 Suppl);GS5-08.
  7. PreludeDX 2016-2017. Data on file

Disclaimer

This information is provided for the sole purpose of disseminating educational information in relation to DCIS and DCISionRT. The content is not intended to provide medical advice or treatment recommendations and should not be relied on as such. The information does not take the place of professional or medical advice. While GenesisCare makes every effort to ensure the accuracy of the content, GenesisCare does not guarantee its accuracy, currency or completeness and does not accept any responsibility or liability for any injury, loss or damage incurred by use of or reliance on the content. Before relying on the content, you should carefully evaluate it and use your own professional discretion when determining its appropriateness for assessing the clinical needs of your patients (including considering any risks relevant to individual patients in the context of their full treatment protocol). The content includes information from third parties. This information is provided for convenience only and does not necessarily reflect the views of GenesisCare or signify that GenesisCare endorses such information.

Find a centre near you